An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)
An Open Label Multi-part First-in-human Study of Oral LMI070 in Infants With Type 1 Spinal Muscular Atrophy An Open Label Multi-part First-in-human Study of Oral LMI070 in Infants With Type 1 Spinal Muscular ...
Clinical trial of LMI070 given by mouth to Type I SMA infant patients.
An open-label multi-part first-in-human study of oral LMI070 in infants with Type 1 spinal muscular atrophy - CLMI070X2201 An open-label multi-part first-in-human study of oral LMI070 in infants with Type 1 spinal muscular ...
United States;Hungary;Czech Republic;Poland;Belgium;Denmark;Bulgaria;Russian Federation;Netherlands;Germany;Italy United States;Hungary;Czech Republic;Poland;Belgium;Denmark;Bulgaria;Russian Federation;Netherlands; ...
Clinical trial of LMI070 given by mouth to Type I SMA infant patients.
An open-label multi-part first-in-human study of oral LMI070 in infants with Type 1 spinal muscular atrophy - CLMI070X2201 An open-label multi-part first-in-human study of oral LMI070 in infants with Type 1 spinal muscular ...
United States;Hungary;Czech Republic;Belgium;Poland;Denmark;Bulgaria;Russian Federation;Netherlands;Germany;Italy United States;Hungary;Czech Republic;Belgium;Poland;Denmark;Bulgaria;Russian Federation;Netherlands; ...